SCHEMBL742211

SCHEMBL742211

COC(=O)c1cc(-c2nnc[nH]2)cc(N2CCCC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 7/20 0.36
KMT2A Q03164 3/20 0.34
SIRT2 Q8IXJ6 1/20 0.34
SIRT1 Q96EB6 1/20 0.34
DGAT2 Q96PD7 1/20 0.34
HPGD P15428 2/20 0.34
MAPT P10636 2/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
MEN1 O00255 2/20 0.33
USP2 O75604 1/20 0.33
GAA P10253 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730915 0.82 KDM4E (0.38) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL731026 0.79 KDM4E (0.40) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL730949 0.78 KDM4E (0.53) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL3510581 0.77 KDM4E (0.55) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL743462 0.75 NPC1 (0.38) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL730950 0.73 ALDH1A1 (0.53) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL21817920 0.72 KDM4E (0.45) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL2276958 0.72 NOTUM (0.49) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
SCHEMBL730837 0.72 KDM4E (0.50) KDM4ENPC1RAB9ANPSR1SMN1; SMN2
Hydrochloric Acid SCHEMBL17113220 0.70 LOXL2 (0.49) KDM4ENPC1RAB9ANPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 KDM4E 3445/4885NPC1 2438/4885RAB9A 2465/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.